welcome to oneFAPvoice
- a positively charged Familial Adenomatous Polyposis community.- join today!
- login
Sulindac/Erlotinib Combo Tested in Patients with Familial Adenomatous Polyposis
A lower duodenal polyp burden was seen after 6 months of treatment with sulindac and erlotinib vs. placebo among patients with familial adenomatous polyposis (FAP), a study published in JAMA reports.

expertly curated content related to this topic
-
Surgical Prophylaxis in Familial Adenomatous Polyposis: Do Pre-Existing Desmoids Outside the Abdominal Cavity Matter...Desmoid tumours (DT) are myofibroblastic...
-
Study identifies enhanced impact of treatment for hereditary cancer patientsPeople with an inherited syndrome called...
-
People with Malfunctioning Ileostomy, Colon or Rectum Removal can be Helped with the BCIR Procedurehttps://www.youtube.com/watch?v=sCoTgn32...
-
Severe Duodenal Involvement in Familial Adenomatous Polyposis Treated by Pylorus-Preserving PancreaticoduodenectomyPURPOSE : Pancreaticoduodenectomy is an ...
-
Primary and Secondary Restorative Proctocolectomy for Familial Adenomatous Polyposis: Complications and Long-Term Bo...AIM : The aim of the study was to evalua...
-
Hereditary Colorectal Cancer Syndromes: American Society of Clinical Oncology Clinical Practice Guideline Endorsemen...Purpose: To provide recommendations on ...
-
The Effect of Ursodesoxycholic Acid on Duodenal Adenomas in Familial Adenomatous Polyposis: A Prospective Randomized...AIM: Duodenal adenomas occur in about 9...